Staar Surgical Company Reports Results For The Quarter Ended June 30: Earnings Summary
STAAR Surgical Company reports results for the quarter ended June 30 - Earnings Summary
STAAR Surgical Company STAA.OQ reported quarterly adjusted earnings of 16 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -34 cents. The mean expectation of ten analysts for the quarter was for earnings of 16 cents per share. Wall Street expected results to range from -1 cents to 26 cents per share.
Revenue rose 111% to $93.54 million from a year ago; analysts expected $90.57 million.
STAAR Surgical Company's reported EPS for the quarter was 16 cents.
The company reported quarterly net income of $8.06 million.
STAAR Surgical Company shares had fallen by 13.1% this quarter and gained 8.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 77.3% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 8 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for STAAR Surgical Company is $29.00, about 14% above its last closing price of $24.94
This summary was machine generated from LSEG data August 12 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.16 | 0.16 | Met |
Mar. 31 2026 | -0.06 | 0.23 | Beat |
Dec. 31 2025 | 0.06 | -0.37 | Missed |
Sep. 30 2025 | 0.16 | 0.18 | Beat |